Aspirin Users Attending for NHS Bowel Cancer Screening Have Less Colorectal Neoplasia: Chemoprevention or False-Positive Faecal Occult Blood Testing?

Objective: The NHS Bowel Cancer Screening Programme (BCSP) uses faecal occult blood (FOB) testing to select patients aged 60–69 years for colonoscopy. Aim: To examine the association between aspirin use and the detection of colorectal neoplasia in screened patients undergoing colonoscopy. Methods: D...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestion 2012-01, Vol.85 (4), p.278-281
Hauptverfasser:	Lee, Thomas J.W., Hull, Mark A., Rajasekhar, Praveen T., Clifford, Gayle M., Ritchie, Mary, James, Peter, McNally, Richard J.Q., Rutter, Matthew D., Rees, Colin J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aspirin - therapeutic use Body Mass Index Chemoprevention Colonoscopy Colorectal Neoplasms - diagnosis Colorectal Neoplasms - prevention & control Cyclooxygenase Inhibitors - therapeutic use Early Detection of Cancer False Positive Reactions Female Humans Male Middle Aged Occult Blood Original Paper Prospective Studies Regression Analysis Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!